Integrative analysis identifies functional prostate cancer risk SNPs in genomic regulatory regions defined as enhancers (2013)
- Authors:
- Autor USP: NOUSHMEHR, HOUTAN - FMRP
- Unidade: FMRP
- Subjects: NEOPLASIAS PROSTÁTICAS; POLIMORFISMO
- Language: Inglês
- Imprenta:
- Publisher place: Marco Island
- Date published: 2013
- Source:
- Título: Abstracts
- Conference titles: Advances in Genome Biology and Technology Conference (AGBT)
-
ABNT
NOUSHMEHR, Houtan et al. Integrative analysis identifies functional prostate cancer risk SNPs in genomic regulatory regions defined as enhancers. 2013, Anais.. Marco Island: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2013. . Acesso em: 28 dez. 2025. -
APA
Noushmehr, H., Coetzee, S. G., Rhie, S. K., Yan, C., Haiman, C. A., Berman, B. P., et al. (2013). Integrative analysis identifies functional prostate cancer risk SNPs in genomic regulatory regions defined as enhancers. In Abstracts. Marco Island: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Noushmehr H, Coetzee SG, Rhie SK, Yan C, Haiman CA, Berman BP, Frenkel B, Coetzee GA. Integrative analysis identifies functional prostate cancer risk SNPs in genomic regulatory regions defined as enhancers. Abstracts. 2013 ;[citado 2025 dez. 28 ] -
Vancouver
Noushmehr H, Coetzee SG, Rhie SK, Yan C, Haiman CA, Berman BP, Frenkel B, Coetzee GA. Integrative analysis identifies functional prostate cancer risk SNPs in genomic regulatory regions defined as enhancers. Abstracts. 2013 ;[citado 2025 dez. 28 ] - Genome-wide fingerprinting of regulatory chromatin to evaluate the tissue specific origins of high-grade serous ovarian cancer
- Epigenomic (DNA methylation and expression) signatures define subsets of both IDHmut and IDHwt glioma with distinct clinical outcomes
- Molecular patterns at regulatory elements diferentially methylated in glioma
- Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning
- Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication
- Tumor-myeloid cell interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma
- DNA methylation signature associated with risk of recurrence in papillary thyroid carcinoma
- DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
- SpidermiR: an R/Bioconductor package for integrative analysis with miRNA data
- Epigenomic glioma subtype evaluation across 31 tumor types
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
